Key Financial Inc’s MiNK Therapeutics INKT Stock Holding History

Key Financial Inc’s Portfolio INKT Stock Details INKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42	Hold	4	–	–	﹤0.01%	1377
2025 Q4	$45	Hold	4	–	–	﹤0.01%	1424
2025 Q3	$59	Hold	4	–	–	﹤0.01%	1441
2025 Q2	$30	Buy	+4	New	+$30	﹤0.01%	1427
2025 Q1	–	Sell	-4	Closed	-$30	–	1399
2024 Q4	$30	Hold	4	–	–	﹤0.01%	1375
2024 Q3	$32	Hold	4	–	–	﹤0.01%	1345
2024 Q2	$41	Hold	4	–	–	﹤0.01%	1328
2024 Q1	$39	Hold	4	–	–	﹤0.01%	1303
2023 Q4	$46	Hold	4	–	–	﹤0.01%	1307
2023 Q3	$47	Hold	4	–	–	﹤0.01%	1331
2023 Q2	$90	Buy	+4	New	+$80	﹤0.01%	1366

Other funds holding INKT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Longbow Finance Lutry, Switzerland $552M AUM 40.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Paladin Partners Hartland, Wisconsin $139M AUM

AGWCA

Annis Gardner Whiting Capital Advisors Tampa, Florida $625M AUM 23.8% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Key Financial Inc's INKT Position: Q1 2026 in Review

Key Financial Inc held its MiNK Therapeutics (INKT) position steady in Q1 2026 at 4 shares worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Key Financial Inc first reported a position in INKT in Q2 2023 and has held it in 11 quarters since. The position peaked at $90 in Q2 2023. 23 funds tracked by Wall St. Rank hold INKT as of Q1 2026.

Key Financial Inc held 4 shares of MiNK Therapeutics worth $42 as of Q1 2026.
Key Financial Inc left its MiNK Therapeutics share count unchanged in Q1 2026.
MiNK Therapeutics made up ﹤0.01% of Key Financial Inc's portfolio in Q1 2026, its #1377 holding.
Key Financial Inc first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 11 quarters since.
Key Financial Inc's MiNK Therapeutics position peaked at $90 in Q2 2023.
23 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.